Select Committee on International Development First Report


In July 2005, at the G8 summit in Gleneagles, G8 leaders made a commitment to:

    "…working with WHO, UNAIDS and other international bodies to develop and implement a package of HIV prevention, treatment and care, with the aim of as close as possible to universal access to treatment for all those who need it by 2010."[1]

This commitment was reaffirmed at the UN Millennium Review Summit, in New York, in September 2005. On 19 October, the Committee announced that it would inquire into HIV/AIDS and the provision of anti-retrovirals (ARVs), inviting organisations and individuals with relevant experience and expertise to submit written evidence.

We received written memoranda from 17 individuals and organisations, and took evidence from two sets of witnesses at Westminster. We would like to thank the following individuals who gave oral evidence: Dr Mandeep Dhaliwal, Head, Care & Impact Mitigation, International HIV/AIDS Alliance and the Stop AIDS Campaign; Dr Tom Ellman, Medical Adviser, Médecins Sans Frontières (UK); Ms Sandra Black, Senior Policy Advisor, HIV/AIDS Department, World Health Organisation (WHO); Mr Ben Plumley, Director, Joint United Nations Programme on HIV/AIDS (UNAIDS) Executive Office; Mr Hans-Martin Boehmer, Head of Human Development Group, Policy Division; Ms Robin Gorna, Senior AIDS adviser and team leader, Policy Division; and, Mr Daniel Graymore, Private Sector Adviser, Global AIDS policy team, Policy Division, Department for International Development (DFID).

1   G8 post-summit communiqué, Gleneagles, Scotland, July 2005 Back

previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 1 December 2005